Company intelligence / Profile preview

DK Biopharma

Thane / Mumbai / Ambernath, Maharashtra, Indiadkbiopharma.com ↗

Ownership: Private
Employees: ~82
Development stage: Preclinical

Overview

DK Biopharma is a rapidly growing Indian CDMO specializing in the development, scale-up, and contract manufacturing of recombinant proteins and other biobased products for global supply. The company focuses on process optimization to reduce costs or increase yields but does not publicly disclose clinical trial results or proprietary drug programs.

Modalities: Recombinant proteinSmall molecule (API/intermediates)
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

asparaginase

Pre-clinical

Indications: Acute lymphoblastic leukemia

Beyond the preview

Go deeper on DK Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DK Biopharma.

Explore the full profile